Company Filing History:
Years Active: 2014-2016
Title: Yanqun Zhang: Innovator in Arginase Inhibitors
Introduction
Yanqun Zhang is a notable inventor based in East Brunswick, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of arginase inhibitors. With a total of 2 patents to his name, Zhang's work focuses on addressing conditions related to arginase activity and nitric oxide levels in mammals.
Latest Patents
Zhang's latest patents include innovative methods and compositions for arginase enzyme inhibitors. These inventions aim to treat or diagnose conditions characterized by either abnormally high arginase activity or abnormally low nitric oxide levels in mammals. The compositions developed by Zhang are designed to be administered to mammals, providing a potential therapeutic avenue for various health issues.
Career Highlights
Throughout his career, Yanqun Zhang has worked with prominent companies in the pharmaceutical industry. Notable among these are Corridor Pharmaceuticals, Inc. and AstraZeneca. His experience in these organizations has contributed to his expertise in developing effective treatments and understanding the complexities of biochemical processes.
Collaborations
Zhang has collaborated with several professionals in his field, including Bruce Edward Tomczuk and Gary Olson. These collaborations have likely enriched his research and development efforts, fostering innovation in his work.
Conclusion
Yanqun Zhang's contributions to the field of arginase inhibitors highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science and improving health outcomes.